149 related articles for article (PubMed ID: 12803507)
1. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Morii T; Fujita H; Narita T; Koshimura J; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
Ren Fail; 2003 May; 25(3):439-44. PubMed ID: 12803507
[TBL] [Abstract][Full Text] [Related]
2. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Morii T; Fujita H; Narita T; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
J Diabetes Complications; 2003; 17(1):11-5. PubMed ID: 12505750
[TBL] [Abstract][Full Text] [Related]
3. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
[TBL] [Abstract][Full Text] [Related]
4. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
[TBL] [Abstract][Full Text] [Related]
5. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Ren Fail; 1995 Jan; 17(1):43-9. PubMed ID: 7770643
[TBL] [Abstract][Full Text] [Related]
6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
7. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Ibrahim S; Rashed L
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):911-7. PubMed ID: 18974575
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
[TBL] [Abstract][Full Text] [Related]
9. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
[TBL] [Abstract][Full Text] [Related]
10. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Branten AJ; Klasen IS; Wetzels JF
Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
González J; Jatem E; Roig J; Valtierra N; Ostos E; Abó A; Santacana M; García A; Segarra A
Nephrol Dial Transplant; 2022 Oct; 37(11):2102-2110. PubMed ID: 35583251
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
[TBL] [Abstract][Full Text] [Related]
16. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.
Amann B; Tinzmann R; Angelkort B
Diabetes Care; 2003 Aug; 26(8):2421-5. PubMed ID: 12882873
[TBL] [Abstract][Full Text] [Related]
18. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
[TBL] [Abstract][Full Text] [Related]
19. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
Banba N; Nakamura T; Matsumura M; Kuroda H; Hattori Y; Kasai K
Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
[TBL] [Abstract][Full Text] [Related]
20. Effect of retinoic acid in experimental diabetic nephropathy.
Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
